Page last updated: 2024-10-26

dilazep and Experimental Leukemia

dilazep has been researched along with Experimental Leukemia in 1 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, NW1

Other Studies

1 other study available for dilazep and Experimental Leukemia

ArticleYear
[Protection of cells by nucleoside transport inhibitor combined with nebularine and the therapeutic effect on transplantable mouse tumors].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1985, Volume: 7, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Benzyl Compounds; Ca

1985